Daniel W. Kulp, Ph.D. - Publications

2010 University of Pennsylvania, Philadelphia, PA, United States 
Organic Chemistry, Chemical Biology, De Novo Protein Design

24 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Steichen JM, Kulp DW, Tokatlian T, Escolano A, Dosenovic P, Stanfield RL, McCoy LE, Ozorowski G, Hu X, Kalyuzhniy O, Briney B, Schiffner T, Garces F, Freund NT, Gitlin AD, et al. HIV Vaccine Design to Target Germline Precursors of Glycan-Dependent Broadly Neutralizing Antibodies. Immunity. PMID 27617678 DOI: 10.1016/j.immuni.2016.08.016  0.92
2016 Briney B, Sok D, Jardine JG, Kulp DW, Skog P, Menis S, Jacak R, Kalyuzhniy O, de Val N, Sesterhenn F, Le KM, Ramos A, Jones M, Saye-Francisco KL, Blane TR, et al. Tailored Immunogens Direct Affinity Maturation toward HIV Neutralizing Antibodies. Cell. 166: 1459-1470.e11. PMID 27610570 DOI: 10.1016/j.cell.2016.08.005  0.92
2016 Sok D, Briney B, Jardine JG, Kulp DW, Menis S, Pauthner M, Wood A, Lee EC, Le KM, Jones M, Ramos A, Kalyuzhniy O, Adachi Y, Kubitz M, MacPherson S, et al. Priming HIV-1 broadly neutralizing antibody precursors in human Ig loci transgenic mice. Science (New York, N.Y.). PMID 27608668 DOI: 10.1126/science.aah3945  0.92
2016 Jardine JG, Kulp DW, Havenar-Daughton C, Sarkar A, Briney B, Sok D, Sesterhenn F, Ereño-Orbea J, Kalyuzhniy O, Deresa I, Hu X, Spencer S, Jones M, Georgeson E, Adachi Y, et al. HIV-1 broadly neutralizing antibody precursor B cells revealed by germline-targeting immunogen. Science (New York, N.Y.). 351: 1458-63. PMID 27013733 DOI: 10.1126/science.aad9195  0.92
2015 Dosenovic P, von Boehmer L, Escolano A, Jardine J, Freund NT, Gitlin AD, McGuire AT, Kulp DW, Oliveira T, Scharf L, Pietzsch J, Gray MD, Cupo A, van Gils MJ, Yao KH, et al. Immunization for HIV-1 Broadly Neutralizing Antibodies in Human Ig Knockin Mice. Cell. 161: 1505-15. PMID 26091035 DOI: 10.1016/j.cell.2015.06.003  0.92
2015 Jardine JG, Ota T, Sok D, Pauthner M, Kulp DW, Kalyuzhniy O, Skog PD, Thinnes TC, Bhullar D, Briney B, Menis S, Jones M, Kubitz M, Spencer S, Adachi Y, et al. Priming a broadly neutralizing antibody response to HIV-1 using a germline-targeting immunogen. Science (New York, N.Y.). PMID 26089355 DOI: 10.1126/science.aac5894  0.92
2015 Crooks ET, Tong T, Chakrabarti B, Narayan K, Georgiev IS, Menis S, Huang X, Kulp D, Osawa K, Muranaka J, Stewart-Jones G, Destefano J, O'Dell S, LaBranche C, Robinson JE, et al. Vaccine-Elicited Tier 2 HIV-1 Neutralizing Antibodies Bind to Quaternary Epitopes Involving Glycan-Deficient Patches Proximal to the CD4 Binding Site. Plos Pathogens. 11: e1004932. PMID 26023780 DOI: 10.1371/journal.ppat.1004932  0.92
2015 Zhang SQ, Kulp DW, Schramm CA, Mravic M, Samish I, DeGrado WF. The membrane- and soluble-protein helix-helix interactome: similar geometry via different interactions. Structure (London, England : 1993). 23: 527-41. PMID 25703378 DOI: 10.1016/j.str.2015.01.009  0.92
2015 Pritchard LK, Spencer DIR, Royle L, Bonomelli C, Seabright GE, Behrens AJ, Kulp DW, Menis S, Krumm SA, Dunlop DC, Crispin DJ, Bowden TA, Scanlan CN, Ward AB, Schief WR, et al. Glycan clustering stabilizes the mannose patch of HIV-1 and preserves vulnerability to broadly neutralizing antibodies Nature Communications. 6. DOI: 10.1038/ncomms8479  0.92
2014 Sok D, Doores KJ, Briney B, Le KM, Saye-Francisco KL, Ramos A, Kulp DW, Julien JP, Menis S, Wickramasinghe L, Seaman MS, Schief WR, Wilson IA, Poignard P, Burton DR. Promiscuous glycan site recognition by antibodies to the high-mannose patch of gp120 broadens neutralization of HIV. Science Translational Medicine. 6: 236ra63. PMID 24828077 DOI: 10.1126/scitranslmed.3008104  0.92
2014 Bates JT, Keefer CJ, Slaughter JC, Kulp DW, Schief WR, Crowe JE. Escape from neutralization by the respiratory syncytial virus-specific neutralizing monoclonal antibody palivizumab is driven by changes in on-rate of binding to the fusion protein. Virology. 454: 139-44. PMID 24725940 DOI: 10.1016/j.virol.2014.02.010  0.92
2013 Smith BC, Underbakke ES, Kulp DW, Schief WR, Marletta MA. Nitric oxide synthase domain interfaces regulate electron transfer and calmodulin activation. Proceedings of the National Academy of Sciences of the United States of America. 110: E3577-86. PMID 24003111 DOI: 10.1073/pnas.1313331110  0.92
2013 Kulp DW, Schief WR. Advances in structure-based vaccine design. Current Opinion in Virology. 3: 322-31. PMID 23806515 DOI: 10.1016/j.coviro.2013.05.010  0.92
2012 Reig AJ, Pires MM, Snyder RA, Wu Y, Jo H, Kulp DW, Butch SE, Calhoun JR, Szyperski T, Szyperski TG, Solomon EI, DeGrado WF. Alteration of the oxygen-dependent reactivity of de novo Due Ferri proteins. Nature Chemistry. 4: 900-6. PMID 23089864 DOI: 10.1038/nchem.1454  0.92
2012 Kulp DW, Subramaniam S, Donald JE, Hannigan BT, Mueller BK, Grigoryan G, Senes A. Structural informatics, modeling, and design with an open-source Molecular Software Library (MSL). Journal of Computational Chemistry. 33: 1645-61. PMID 22565567 DOI: 10.1002/jcc.22968  0.92
2011 Gront D, Kulp DW, Vernon RM, Strauss CE, Baker D. Generalized fragment picking in Rosetta: design, protocols and applications. Plos One. 6: e23294. PMID 21887241 DOI: 10.1371/journal.pone.0023294  0.92
2011 Korendovych IV, Kulp DW, Wu Y, Cheng H, Roder H, DeGrado WF. Design of a switchable eliminase. Proceedings of the National Academy of Sciences of the United States of America. 108: 6823-7. PMID 21482808 DOI: 10.1073/pnas.1018191108  0.92
2011 Donald JE, Kulp DW, DeGrado WF. Salt bridges: geometrically specific, designable interactions. Proteins. 79: 898-915. PMID 21287621 DOI: 10.1002/prot.22927  0.92
2010 Berger BW, Kulp DW, Span LM, DeGrado JL, Billings PC, Senes A, Bennett JS, DeGrado WF. Consensus motif for integrin transmembrane helix association. Proceedings of the National Academy of Sciences of the United States of America. 107: 703-8. PMID 20080739 DOI: 10.1073/pnas.0910873107  0.92
2009 Zhang Y, Kulp DW, Lear JD, DeGrado WF. Experimental and computational evaluation of forces directing the association of transmembrane helices. Journal of the American Chemical Society. 131: 11341-3. PMID 19722646 DOI: 10.1021/ja904625b  0.92
2009 Metcalf DG, Kulp DW, Bennett JS, DeGrado WF. Multiple approaches converge on the structure of the integrin alphaIIb/beta3 transmembrane heterodimer. Journal of Molecular Biology. 392: 1087-101. PMID 19527732 DOI: 10.1016/j.jmb.2009.06.032  0.92
2009 Miller MW, Basra S, Kulp DW, Billings PC, Choi S, Beavers MP, McCarty OJ, Zou Z, Kahn ML, Bennett JS, DeGrado WF. Small-molecule inhibitors of integrin alpha2beta1 that prevent pathological thrombus formation via an allosteric mechanism. Proceedings of the National Academy of Sciences of the United States of America. 106: 719-24. PMID 19141632 DOI: 10.1073/pnas.0811622106  0.92
2006 Cegelski L, Steuber D, Mehta AK, Kulp DW, Axelsen PH, Schaefer J. Conformational and quantitative characterization of oritavancin-peptidoglycan complexes in whole cells of Staphylococcus aureus by in vivo 13C and 15N labeling. Journal of Molecular Biology. 357: 1253-62. PMID 16483598 DOI: 10.1016/j.jmb.2006.01.040  0.92
2005 McLaughlin WA, Kulp DW, De La Cruz J, Lu XJ, Lawson CL, Berman HM. A structure-based method for identifying DNA-binding proteins and their sites of DNA-interaction Journal of Structural and Functional Genomics. 5: 255-265. PMID 15704013  0.92
Show low-probability matches.